RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. QUIBIM

QUIBIM

Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.

Health and bioPlug and Play
Latest funding

$50M Series A ·

Led by Asabys Partners · Source: fundraisingfox.com

Total raised: $59.73M across 3 sourced rounds

All 4 rounds ↓
Website: quibim.com.
X: @QuibimBiomarker · 1,851 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Health & Longevity.
Stage: Series A.
Based in: Spain.
Founded: 2012.
Total raised: $59.73M in 3 sourced rounds.
Last round: Feb 25, 2025 · 625 days ago.
Headcount: 51–100 employees.
On Recent Funding since: Sep 28, 2026.

Signals

X account@QuibimBiomarker · created Mar 8, 2014 (12 years old) · 1,851 followers
Website registeredOct 20, 2012 (14 years old)
TIMELINE · MONEY RAISED

QUIBIM | 1529 days from website to first raise on record

@QuibimBiomarker·Raised $60M in 3 sourced rounds·2 signals before the first raise
$15M$30M$45M$60MNOVSEPJULMAYMARJAN 2022NOVSEP$60M||WEBSITE CREATED · OCT 20, 2012||X ACCOUNT CREATED @QUIBIMBIOMARKER · MAR 8, 2014$574.5K Seed · Dec 27, 2016$574.5K SEED · DEC '16$9.15M Seed · Jul 21, 2020$9.15M SEED · JUL '20$50M Series A · Feb 25, 2025$50M A · FEB '25

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

  1. Series A · $50M
  2. Alberta Health Batch 5
  3. Seed · $9.15M
    Source: sifted.eu
  4. Seed · $574.5K
    Source: quibim.com
  5. X account created
  6. Website created

Founders and team

Investors

Companies like QUIBIM

Other companies backed by Asabys Partners

Asabys Partners portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/quibim (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy